Acepodia to Present Late-breaking Poster Presentation Supporting the Potential of its NK Cell Therapy in Solid Tumors at The Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting

◼ ACE1702 demonstrates enhanced cytotoxicity against multiple HER2-expressing cell lines and activity under immunosuppressive conditions
◼ ACE1702 maintains activity following cryopreservation
◼ oNK cell expression profiling reveals high levels of activating receptors and low levels of inhibitory receptors

More >>